About Integrated Development Associates
Integrated Development Associates is a company based in Tokyo (Japan) founded in 2004 was acquired by Chiltern International in May 2017. Integrated Development Associates operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Parexel and Emmes, among others.
- Headquarter Tokyo, Japan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Chiltern International
(May 31, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Integrated Development Associates
Detailed funding history for Integrated Development Associates
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Integrated Development Associates
Integrated Development Associates has secured backing from 1 investor. Prominent investors backing the company include Chiltern International.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Full service CRO with expertise in oncology related development services
|
Locked | Locked | Locked |
Investor details for Integrated Development Associates
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Integrated Development Associates
Investment portfolio details for Integrated Development Associates
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Integrated Development Associates
Detailed financials for Integrated Development Associates
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Integrated Development Associates Comparisons
Peer comparison for Integrated Development Associates
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Integrated Development Associates
Integrated Development Associates operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Parexel and Emmes, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of Integrated Development Associates
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Integrated Development Associates
Complete news archive for Integrated Development Associates
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Integrated Development Associates
Integrated Development Associates was founded in 2004.
Integrated Development Associates is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Integrated Development Associates (IDA), acquired by Chiltern in May, 2017, is a full-service CRO also specialising in providing product development and regulatory consulting services mainly for new biopharmaceutical products in Japan and Asia. Their key service offerings include development of the market entry strategy (medical and scientific analysis, product positioning in Japan), regulatory services (KOL interactions, PMDA interactions), comprehensive clinical development services (turnkey Phase 1 and Phase 2-4 implementation), Clinical Trial In-Country Caretaker (CT-ICC) services for Japanese clinical trial conduct, and filing and maintenance of official submissions to MHLW on behalf of clients. The company claims to be one of the 5 companies to have received SAKIGAKE Designation (breakthrough therapy) from the Japanese authorities. IDA has experience in a wide range of therapeutic areas including CNS, metabolic, cardiovascular and infectious diseases, oncology (almost all types) and orphan diseases. They also have experience in developing cell therapies and regenerative medicine.
Integrated Development Associates's top competitors include Emmes, Syneos Health and ClinChoice.
Integrated Development Associates has 1 investor. Key investors include Chiltern International.